biofit pharmageuticats ltii. bbm !90. tel. 11112, i o1s. … of share... · 2019. 5. 2. ·...
TRANSCRIPT
Bbm@
BIOFIT GHEMIGATS & PHARMAGEUTICATS LTII.!"90. Office : 11112, Sector-E, Sanwer Road, Industrial Area, Indore - 452 O1S. Fax: 0711-2723017Tel. : 0731-2723016,4066216 E-mail : [email protected] i bcplcomptiancegtmait.connFactory : Plot No. 8, sector - lV Kheda IndustrialRrealpitrampur Distt. Dnar 1trl.e.;
Admn. office : B'-121B.,lndustriat Estate, pologround, lndore - 4s2 015 (M.p.)TeL:0731-2426700,2426718,2524003,fax:Ozgt-Z426726oGtN: L242g3Mp1g8SpLC0o2709
Date: 26.04.2019
Dear Sir/ Madam,
Sub.:SubmissionofReconciliationofShareCapitalAuditvideCircularNo.D&CC/FITTC/C W-tolzooz dated n"..J". 31" zooz iem""a"a vide circular No'
CrR/MRD/D pl30/zot'dated 06-09-2il;i"""t"a by SEBI for the quarter ended 31't March
20:19.
Ref: 'SIN
code: INEB29A01014; scRIPE coDE; 5243g6,scRIP NAME: BIOFILCHEM
As per Direcrive of SEBI vide irs circular No. D & cc/Ftrrc/clR-1612002^!a"ted December 31"
2002 [Amendeo vioJ-cir.utu, No. crn/rvrn iiri tz9/t010 daied 06-09-2010) issued bv SEBI' we
are enclosing neconciliarion of st,ure capiiri irai, cerrificate in revised format issued by practicing
company secretary #;;;il;er ended on 31't March 2019for the same'
Thanking You,
Yours FaithiullYicals Ltd"
WCS Shikha Khilwani
CompanY Secretary &
ComPliance Officer
To,
The ComPanY Secretary'
N;;;;;i!,oik Exchange of India Ltd"
Exchange Plaza, C-1, Block G'
Bandra Kurla ComPlex'
gandra (E) Mumbai - 400 051
To,
The ComPanY Secretary'
BSE Ltd,
Phiroze )eeieebhoY Towers
Dalal Street
Mumbai- 400001
Enc a7a
L.N. JOSHI & CO. 306, Sterltng Arcade, 3rd Floor, 15/3, Race Course Road, OpP. IDA Building, I ndore · 452 003 (M.P.) (NOlAos PRACTISI NG COMPANY SECRETARIES Ph.:(073 1) 4266708, E-mail : [email protected]
To,
The Board of Directors
BIOFIL CHEMICALS & PHARMACEUTICALS LTD.
11/12, Sector "E" Sanwer Road, Industrial Area,
Indore 452015.
CERTIFICATE OF RECONCILIATION OF SHARE CAPITAL AUDIT
We have examined all relevant Books, Registers, Forms. Documents and papers maintained by BIOFIL CHEMICALS & PHARMACEUTICALS LIMITED (hereinafter referred
to as 'the Company') and its Registrar & Share Transfer Agent AN KIT CONSULTANCY
PRIVATE LIMITED having office at 60, Electronic Complex, Pardeshipura, Indore452010
M.P, for the purpose of issuing Reconciliation of Share Capital Audit Certificate , in accordance with Circular No. 0 & CC/F1TTC/CIR·16/2002 dated December 31 1t 2002 (Amended vide Circular No. CIRlMRDJOP/30/2010 dated 06092010) issued by the
Securities and Exchange Board of India for the quarter ended 31 st March 2019.
In our opinion and to the best of our knowledge and according to the information and
explanations given to us and based on such verification as considered necessary, we
hereby certlly thaI:
1. For Quarter Ended 31" March 2019
2. ISIN INE829A01014
3. Script Code
SSE
NSE
524396
SIOFILCHEM
4. Face Va lue Rs. 10/- each
5. Name of the Company BIOFtL CHEMICALS & PHARMACEUTICALS LTD.
6. Registered Office & Telephone No. 11/12, Sector "E" Sanwer Road, Industrial Area,
Indore 452015
Tel No.: 07312723018
7 Correspondence Address & Telephone
No.
11 /12, Sector "E" Sanwer Road, Industrial Area,
Indore 452015 Tel No. 07312723018
8. Email Address bcplcompliance@gmal l.com
9 Name of Stock Exchanges where the
Company 's securities are listed :
The National Stock Exchange Ltd, Mumbai
The Bombay Stock Exchange, Mumbai
Gonld ... 2 ~ ~~ . J OS" ,~ .
~ '" .o'VOo ~ ~ ~ ..,\. "." .1"6''1'", ~C
~:~ r:;;'. BIOFIL CHEMICALS & PHARMACEUTICALS LI
~
D .
2-
i I II
10561300
100 Rs. 162738000/*
wise)
I i in
3450000 21 .20%
action is pending due to listing confirmation hence still nol
I I j I I
·ls5ued in demate mode but corporate
*Notes:
a) Issued capital includes reissue of 5712500 forfeited Equity shares.
b) 34,50,000 forfeited equity shares were reissued in demate mode (CDSL) but corporate action and trading confirmation is still pending therefore shares have not
been dematerialized till date of this certificate, hence same has been mentioned separately. Further As informed by the management application for listing of aforesaid shares is pending with stock Exchanges.
16 Reasons for difference if any, betwee On 31 .03.2011 Company has reissued 5712500 (i) (10&11) forfeited equity shares and listing confirmation for
above shares pending at Stock Exchanges.
(ii) Reasons for difference if any, betwee Nil (10&15)
(iii ) Reasons for difference if any, betwee On 3103.2011 Company has reissued 5712500 (11&15) forfeited equity shares and listing confirmation for
above shares oendioQ at Stock Exchanqes.
17. There is no change in share capital during the Quarter ended 31 $1 March. 2019.
18. Register of Members is updated (yes/no) YES (maintained by R&STA) if not updated up to which date
19. Reference of previous quarter with regard to excess dematerialized shares, if any, N.A,
20. Has the Company resolved the matter mentioned in point No.19 above in the Current quarter? if not reason why? N.A,
21 . All the dematerialization and rematerialization requests received during the quarter 31 st ended March, 2019 have been duly confirmed within 21 days except 2 demate
requests aggregating to 400 shares which were confirmed after 21 days from the date
of DRN set up. "*
22 As on the date of this certificate, there are no cases of demate request received during the quarter ended 31 $1 March, 2019 pending for confirmation beyond 21 days except 2 demate requests aggregating to 400 shares which were confirmed after 21 days from
the date of DRN set up.· Conld ... 3
BIOFIL CHEMICALS & PHARMACEUTICALS LTD
·3·
23 Name, Telephone & Fax No. of the Compliance officer of the Company:
Ms.Shikha Khilwani, Company Secretary and Compliance officer
Membership number: A43203
11 /12, Seclor "E' Sanwer Road, Induslrial Area, rndore452015
Email bcplcompliance@gmail .com
PH 0731·2426718
24 Name Address Tel. & Fax No. Registration No. of the Secretarial Auditor.
L.N.Joshi & Company
Company Secretaries 306, Sterling Arcade, 15/3 Race Course Road, Indore PH 0731·4266708
C.P . No. 4216 M.No.5201 Emailld:lnjoShics@g mail.com
25 Appointment of Common Agency for
Share regislry work
AN KIT CONSULTANCY PRIVATE LIMITED
SEBI REG. No. INROOOOO0767
CIN NO· U74140MP1985PTC003074 60. Electronic Complex, Pardeshipura Indore· 452010 (M.P.) TeI.:07314065799, 4065797
Fax:07314065798
Email : ankil_ [email protected]
Web Address: WNIN.ankitonline.com
26. Any other detail that the auditor may like 10 provide. (e.g BIFR Company, delisting
from Stock Exchange , Company changed its name etc.)
• As on 31 $1 Oay of March 2011 Company has reissue of 57,12.500 forfeited equity shares at price of RS,71· each (face value Rs.10 each) on a preferential basis to promoters and
non promoters of the company, pursuant to the specia l resolution passed under Section
81(lA) of Ihe Companies Acl, 1956 by Ihe shareholders of Ihe Company al their Extra
Ordinary General Meeting held on 23(d Day of March 2011 .
• 34,50,000 equity shares issued in de mate form and 22,62,500 equity shares were issued
in physical form to allottees and listing confirmation and corporate action are pending for the same Hence above shares separately shown.
• The shareholders have passed special resolution in their annual general meeting held on 24 tll September. 2015 for payment of remaining amount of Rs.3/· from those
shareholders, to whom shares were allo tted on 31 st March, 2011 .
• SEBt vide its tetter reference no. MRDIDOP2JDSA2JOWI201912498/1 dated January 24, 2019 has granted relaxation in timelines for proceSSing of DRNs to 30 days till
June 30th 2019 from current 15 days as specified in regulation 74(5) of SEBI
(Depository & Participants) Regulations 2018.
Place: Indore Dale. 2104.2019
BIOFIL CHEMICALS & PHARMACEUTICALS LTD